You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18-359

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

Recruiting
  • Metastatic Cancer
  • +5 more
  • Stereotactic Body Radiotherapy
  • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
  • Hartford, Connecticut
  • +9 more
Nov 17, 2022

Measures of Smokeless Tobacco Use: Study 1

Completed
Has Results
  • Smokeless Tobacco Use
  • Tobacco Dependence
    • Minneapolis, Minnesota
    • +2 more
    Nov 23, 2022

    Melanoma Trial in Worldwide (Relatlimab, Nivolumab)

    Active, not recruiting
    Has Results
    • Melanoma
    • Relatlimab
    • Nivolumab
    • Tucson, Arizona
    • +126 more
    Mar 2, 2022

    COVID-19 Trial in Burgos, Madrid (ApTOLL, Saline)

    Recruiting
    • COVID-19
    • Burgos, Spain
    • +3 more
    Sep 28, 2022

    Resilience and Loneliness in Youth During COVID-19 Pandemic

    Completed
    • Resilience, Psychological
    • +3 more
    • Survey and Questionnaire
    • Brussels, Belgium
      Erasme University Hospital
    Feb 8, 2022

    Hepatocellular Carcinoma Trial in Nanjing (Idarubicin Hydrochloride for Injection)

    Recruiting
    • Hepatocellular Carcinoma
    • Idarubicin Hydrochloride for Injection
    • Nanjing, Jiangsu, China
      Zhongda Hospital, Southeast University
    Dec 28, 2022

    Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Degludec)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • Little Rock, Arkansas
    • +121 more
    Jan 14, 2022

    Premature Birth Trial in Milan (Early Intervention)

    Active, not recruiting
    • Premature Birth
    • Early Intervention
    • Milan, Italy
      NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
    Feb 2, 2023

    End Button Tenodesis in Failed Developmental Dysplasia of Hip

    Not yet recruiting
    • Orthopedic Disorder
    • Tenodesis by end button
    • (no location specified)
    Oct 29, 2022

    Parkinson Disease Trial in Worldwide (Tavapadon, Placebo)

    Recruiting
    • Parkinson Disease
    • Phoenix, Arizona
    • +145 more
    Dec 20, 2022

    The Oldest-Old Population.(NEUROPSIC-GR)

    Not yet recruiting
    • Dementia
    • Cognition Disorders in Old Age
      • (no location specified)
      Jul 28, 2022

      Abdominal Cancer, Malignancy Trial in Pittsburgh (Lipopolysaccharide)

      Recruiting
      • Abdominal Cancer
      • Malignancy
      • Lipopolysaccharide
      • Pittsburgh, Pennsylvania
      • +1 more
      Feb 28, 2023

      Ligamentoplasty of Ligamentum Tere Developmental Dysplasia of

      Not yet recruiting
      • Orthopedic Disorder
      • ligamentoplasty of ligamentum teres
      • (no location specified)
      Oct 29, 2022

      HCC Trial in Hong Kong (procedure, radiation, drug)

      Active, not recruiting
      • HCC
      • TACE
      • +2 more
      • Hong Kong, Hong Kong
        Department of Clinical Oncology
      Oct 24, 2022

      Fracture Humerus Trial in Pittsburgh (Tranexamic acid (TXA), Saline)

      Not yet recruiting
      • Fracture Humerus
      • Tranexamic acid (TXA)
      • Saline
      • Pittsburgh, Pennsylvania
        Allegheny Health Network Allegheny General Hospital
      Apr 5, 2023

      Pattern of Microbial Infection in AECOPD Patients and Its

      Not yet recruiting
      • Acute Exacerbation COPD
        • (no location specified)
        Nov 3, 2023

        Selecta Laser Trabeculoplasty in Patients Undergoing Filtering

        Completed
        • Glaucoma
          • Paris, Ile-de-France, France
            Groupe Hospitalier Paris Saint Joseph
          Jun 2, 2023

          CNS Diseases, Pediatric Disorder, Body Indication Trial in Worldwide (Gadopiclenol)

          Recruiting
          • Central Nervous System Diseases
          • +2 more
          • Cincinnati, Ohio
          • +11 more
          Oct 21, 2022

          Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

          Recruiting
          • Advanced Hepatocellular Carcinoma
          • Bifidobacterium Bifidum Oral Product
          • Guangzhou, Guangdong, China
            The Third Affiliated Hospital of Sun Yat-Sen University
          Nov 16, 2022

          Thoracic Esophageal Squamous Cell Carcinoma Trial in GuangZhou (adjuvant chemo, standard two field Lymphadenectomy, Total two

          Completed
          • Thoracic Esophageal Squamous Cell Carcinoma
          • adjuvant chemotherapy
          • +3 more
          • GuangZhou, Guangdong, China
            Sun Yat-sen Uniersity Cancer Center
          Mar 30, 2022

          Pain, Patient Reported Outcomes and Complementary and

          Enrolling by invitation
          • Chronic Musculoskeletal Pain
          • Practitioner-delivered CIH therapies (acupuncture, therapeutic massage, chiropractic care) as received in VHA and community practice settings
          • +2 more
          • Sepulveda, California
          • +1 more
          Apr 28, 2022

          Hip Fractures, Anemia, Complication,Postoperative Trial in Istanbul (Ferric carboxymaltose)

          Recruiting
          • Hip Fractures
          • +2 more
          • Ferric carboxymaltose
          • Istanbul, Çapa / Fatih, Turkey
            Istanbul University, Istanbul Faculty of Medicine, Department Or
          Oct 8, 2023

          Influenza Trial in Bardstown, Metairie, Salt Lake City (Fluzone Quadrivalent vaccine, 2018-2019 formulation, Flublok

          Completed
          Has Results
          • Influenza
          • Fluzone Quadrivalent vaccine, 2018-2019 formulation
          • +2 more
          • Bardstown, Kentucky
          • +2 more
          Mar 15, 2022

          Squamous Cell Carcinoma of the Oropharynx Trial in Paris (Tumor Biopsy)

          Not yet recruiting
          • Squamous Cell Carcinoma of the Oropharynx
          • Tumor Biopsy
          • Paris, France
          • +2 more
          Sep 25, 2023

          Using Microbiome to Predict Durvalumab Toxicity in Post-

          Recruiting
          • NSCLC, Stage III
          • Locally Advanced Lung Carcinoma
            • Kansas City, Kansas
            • +1 more
            May 17, 2022